Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway

Jinghui Sun(Jilin University), Guanbin Song(Chongqing University), Yang Xianjiong(Guiyang Medical University), Shunqin Zhu(Southwest University), Qing Luo(Chongqing University), Lingling Liu(Henan Agricultural University)
Toxicology
April 8, 2017
Cited by 57


Related Papers